Vitiligo-like lesions following immunotherapy with IFNα and IL-2 in melanoma patients
- 1 January 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (8) , 1209-1211
- https://doi.org/10.1016/0959-8049(94)90493-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsImmunology Today, 1993
- Vitiligo autoantibodies are effective against melanomaCancer, 1993
- Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trialsCancer, 1993
- An immunohistological study of cutaneous lymphocytes in vitiligoThe Journal of Pathology, 1993
- Cytolytic Antibodies to Melanocytes in VitiligoJournal of Investigative Dermatology, 1993
- Sequential chemoimmunotherapy in the treatment of metastatic melanoma.Journal of Clinical Oncology, 1992
- Identification of Pigment Cell Antigens Defined by Vitiligo AntibodiesJournal of Investigative Dermatology, 1992
- Vitiligo-Like Depigmentation and Morpheas after Specific Intralymphatic Immunotherapy for Malignant MelanomaDermatology, 1992
- Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in VitiligoJournal of Investigative Dermatology, 1991
- Vitiligo and Cutaneous MelanomaDermatology, 1991